Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: Tel Aviv
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Redhill Biopharma Ltd

+ Add to Watchlist

RDHL:IT

382.00 ILs 13.90 3.51%

As of 09:24:40 ET on 05/23/2013.

Company Profile for Redhill Biopharma Ltd (RDHL)

Redhill Biopharma Ltd. develops and manufactures pharmaceuticals. The Company acquires and further developes late-stage clinical trial formulations of existing drugs.

Contact Information

Redhill Biopharma Ltd

21 Ha arba a St
Tel Aviv, 64739
Israel
Phone: 972-03-541-3131
Fax: 972-03-541-3144

Key Executives for Redhill Biopharma Ltd (RDHL)

Dror Ben-AsherChairman/CEOOri ShiloDpty CEO:Finance & Operations
Uri Hananel AharonChief Accounting OfficerGuy GoldbergChief Business Officer
Ira N KalfusChief Medical OfficerGilead RadaySenior VP:Product & Corporate Development
Adi FrishSenior VP:Business DevReza FathiSenior VP:Research & Development
Thomas A Lang "Tom"VP:Regulatory & Clinical AffairsPascal WeertsDir:Corporate & Legal Affairs
Clara FehrmannProduct ManagerElkan R GamzuProduct Manager
Patrick Laughlin McLeanProduct Manager

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil